RPG Life Sciences Share Price
Start SIP in RPG Life Sciences
Start SIPRPG Life Sciences Performance
Day Range
- Low 2,193
- High 2,311
52 Week Range
- Low 1,225
- High 2,422
- Open Price2,300
- Previous Close2,300
- Volume20338
Rpg Life Sciences Investment Rating
-
Master Rating:
-
R P G Life Sciences has an operating revenue of Rs. 599.69 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 20% is great, ROE of 23% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 41% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 165 | 127 | 154 | 154 | 148 | 118 |
| Operating Expenses Qtr Cr | 126 | 106 | 116 | 116 | 116 | 103 |
| Operating Profit Qtr Cr | 39 | 21 | 38 | 37 | 32 | 16 |
| Depreciation Qtr Cr | 5 | 4 | 4 | 4 | 4 | 4 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 9 | 5 | 9 | 9 | 8 | 3 |
| Net Profit Qtr Cr | 27 | 13 | 26 | 26 | 22 | 10 |
RPG Life Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹2,212.42
- 50 Day
- ₹2,048.23
- 100 Day
- ₹1,870.51
- 200 Day
- ₹1,670.40
- 20 Day
- ₹2,211.27
- 50 Day
- ₹2,025.78
- 100 Day
- ₹1,769.86
- 200 Day
- ₹1,631.28
RPG Life Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 2,293.42 |
| Second Resistance | 2,361.53 |
| Third Resistance | 2,411.62 |
| RSI | 54.43 |
| MFI | 73.73 |
| MACD Single Line | 84.92 |
| MACD | 76.18 |
| Support | |
|---|---|
| First Support | 2,175.22 |
| Second Support | 2,125.13 |
| Third Supoort | 2,057.02 |
RPG Life Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 21,418 | 1,087,820 | 50.79 |
| Week | 41,153 | 2,302,488 | 55.95 |
| 1 Month | 38,874 | 1,633,081 | 42.01 |
| 6 Month | 37,191 | 1,303,912 | 35.06 |
RPG Life Sciences Result Highlights
RPG Life Sciences Synopsis
NSE-Medical-Diversified
Rpg Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 582.05 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2024. RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354.| Market Cap | 3,804 |
| Sales | 600 |
| Shares in Float | 0.45 |
| No of funds | 48 |
| Yield | 0.7 |
| Book Value | 10.15 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | |
| Alpha | 0.2 |
| Beta | 0.57 |
RPG Life Sciences Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 72.81% | 72.81% | 72.81% | 72.81% |
| Mutual Funds | 1.65% | 1.47% | 1.08% | 0.82% |
| Insurance Companies | 0.51% | 0.51% | 0.51% | 0.51% |
| Foreign Portfolio Investors | 1.15% | 0.9% | 0.56% | 0.46% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 16.79% | 17.4% | 18.16% | 18.41% |
| Others | 7.08% | 6.9% | 6.87% | 6.98% |
RPG Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Harsh V Goenka | Chairman |
| Mr. Yugal Sikri | Managing Director |
| Mr. Rajat Bhargava | Non Executive Director |
| Mr. Sachin Nandgaonkar | Independent Director |
| Mr. Manoj K Maheshwari | Independent Director |
| Mr. Narendra Ambwani | Independent Director |
| Ms. Zahabiya Khorakiwala | Independent Director |
| Mr. Bhaskar Iyer | Independent Director |
| Dr. Lalit S Kanodia | Independent Director |
| Mr. Mahesh S Gupta | Independent Director |
| Mr. Hiten Kotak | Independent Director |
| Mr. Anil Matai | Independent Director |
| Ms. Radhika Gupta | Independent Director |
RPG Life Sciences Forecast
Price Estimates
RPG Life Sciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-19 | Quarterly Results | |
| 2024-04-30 | Audited Results & Final Dividend | |
| 2024-02-01 | Quarterly Results | |
| 2023-10-18 | Quarterly Results | |
| 2023-07-28 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-06-28 | FINAL | Rs.16.00 per share(200%)Final Dividend |
| 2023-07-21 | FINAL | Rs.12.00 per share(150%)Final Dividend |
| 2022-07-15 | FINAL | Rs.9.60 per share(120%)Final Dividend |
| 2021-08-17 | FINAL | Rs.7.20 per share(90%)Dividend |
RPG Life Sciences FAQs
What is Share Price of RPG Life Sciences ?
RPG Life Sciences share price is ₹2,225 As on 18 September, 2024 | 02:31
What is the Market Cap of RPG Life Sciences ?
The Market Cap of RPG Life Sciences is ₹3680.4 Cr As on 18 September, 2024 | 02:31
What is the P/E ratio of RPG Life Sciences ?
The P/E ratio of RPG Life Sciences is 39.9 As on 18 September, 2024 | 02:31
What is the PB ratio of RPG Life Sciences ?
The PB ratio of RPG Life Sciences is 9.8 As on 18 September, 2024 | 02:31